- Coordinator
- Universitat De Valencia, Spain
- Runs
- 1 December 2026 to 30 November 2031
- Status
- Running
- EU funding
- €1.5m
- Total cost
- €1.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101300041
What the project is doing
In the project's own words, from its summary on CORDIS.
Human endogenous retroviruses (HERVs) are remnants of ancient exogenous retroviruses that make up nearly 9% of the human genome. Though long dismissed as “junk” DNA, recent advances have revealed that thousands of HERV-derived open reading frames are actively expressed and translated in healthy human tissues and various pathologies. Aside from a few well-characterized examples, such as the placental syncytins, the biological functions of the vast majority of HERV-derived proteins are unknown.
This project will focus on HERV-derived envelope proteins (HERV-Envs) because their ability to interact with receptors makes them strong candidates for functional co-option by the host. The overarching goal of this project is to systematically uncover novel physiological and pathological roles of a large panel of HERV-Envs. First, we will search for novel HERV-Env receptors and receptor-dependent activities using high-throughput viral pseudotyping, comparative transcriptomics, genome-wide CRISPR screens, and structure-based bioinformatic predictions.
Next, we will investigate the cellular pathways modulated by HERV-Envs through state-of-the-art CRISPR-based genome editing and single-cell transcriptomics. We will then explore the antiviral potential of HERV-Envs by testing how they impact the entry and evolution of exogenous retroviruses using viral pseudotyping and experimental evolution. Finally, we will conduct the largest HERV-Env serological screening to date, measuring and comparing antibody responses to HERV-Envs in health and disease, and isolating anti-HERV-Env monoclonal antibodies with therapeutic potential.
This project will deliver the first comprehensive functional characterization of HERV-Envs, which will challenge the prevailing view of endogenous retroviral envelopes as passive genomic relics of past viral infections and reveal their active roles in human physiology and disease.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universitat De Valencia | Valencia | Spain | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI